All News #Library
Rare Diseases
Protalix &Chiesi Global Rare Diseases Announce USFDA (BLA) for Pegunigalsidase
11 Aug 2020 //
PRNEWSWIRE
Chiesi creates Boston rare disease unit ahead of Fabry launch
08 Feb 2020 //
FIERCE BIOTECH
Horizon Pharma plc Announces Agreement to Sell European Marketing Rights to PROCYSBI
23 May 2017 //
NASDAQ

Market Place
Sourcing Support